Thrivent Financial for Lutherans
OPRX icon

Thrivent Financial for Lutherans’s OptimizeRx OPRX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,595
Closed -$296K – 2487
2022
Q4 		$296K Sell
17,595
-1,036
-6% -$17.9K ﹤0.01% 2262
2022
Q3 		$276K Buy
18,631
+797
+4% +$15.8K ﹤0.01% 2256
2022
Q2 		$488K Buy
17,834
+3,368
+23% +$99.8K ﹤0.01% 2108
2022
Q1 		$546K Buy
14,466
+5
+0% +$221 ﹤0.01% 2154
2021
Q4 		$898K Buy
+14,461
New +$1.1M ﹤0.01% 1915

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Thrivent Financial for Lutherans's OPRX Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 17,595 shares — an estimated $296K sold.

Thrivent Financial for Lutherans first reported a position in OPRX in Q4 2021 and held it in 5 quarters. The position peaked at $898K in Q4 2021. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 17,595 OptimizeRx shares in Q1 2023, an estimated $296K.
  • Thrivent Financial for Lutherans first reported a position in OptimizeRx in Q4 2021 and held it in 5 quarters.
  • Thrivent Financial for Lutherans's OptimizeRx position peaked at $898K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.